Dedicated versus off-label transcatheter devices for pure native aortic regurgitation via transfemoral access: a meta-analysis of contemporary outcomes
AsiaIntervention 2026;12:225-235
Differences between Japan and France in transcatheter aortic valve implantation: insights from the TOTO-TAVI study
AsiaIntervention 2026;12:181-190
A semi-rapid deployment workflow to reduce device time in Evolut FX self-expanding transcatheter aortic valve implantation
AsiaIntervention 2026;12:191-200
Clinical evaluation of the Hydra self-expanding THV: 30-day results from the GENESIS-II study
AsiaIntervention 2025;11:155-163